Home News EyePromise® Launches the Next Generation of MPOD Measurement Device

EyePromise® Launches the Next Generation of MPOD Measurement Device

XPro to measure mpod
The Zx Pro

EyePromise announces the latest addition to its its comprehensive nutritional system with a portable device to measure macular pigment optical density (MPOD). The new Zx Pro™ is the latest in biomarker technology and allows eye care professionals to measure MPOD in a larger patient base. This portable, intuitive device is equipped with an audio tutorial, making the need for staff-run exams discretionary and ensuring each test is completed accurately.

Using clinically proven technology called heterochromatic flicker photometry, the Zx Pro’s two-minute ocular test provides a score that directly correlates to the amount of dietary zeaxanthin and lutein in the eyes. This gives doctors a quantified measure to associate with patients’ level of risk. Low macular pigment optical density (MPOD) scores are a risk factor for several eye and overall health concerns, including blue light damage, poor contrast, difficulty seeing at night, light sensitivity, cognitive concerns, and of course, age-related eye health issues.


Pinakin Davey, PhD, OD, FAAO, one of the clinical experts behind the research that developed the Zx Pro, explained, “The idea for the Zx Pro grew from an understanding that MPOD is an invaluable biomarker combined with a need for a device that’s portable, creating flexibility for both research and practice. We also wanted to include features such as the audio tutorial to reduce staff requirements and variability of the exam explanation from patient to patient. It’s the latest cutting-edge technology to improve early patient identification and intervention. A remarkable achievement for both clinical and practical use.”

The Zx Pro joins EyePromise’s comprehensive line of clinically proven nutraceuticals and the Auto Refill Program (ARP)  patient compliance program. These are all part of the new Zea Performance System™, the nutritional program that helps deliver vision for life through a turnkey solution for MPOD measurement, nutraceutical prescription, a compliance program and patient and practice support.

For more information, visit eyepromise.com/zea-performance-system.

Read other stories about macular pigment and supplementation here.

- Advertisment -

Most Popular

From Urban Academia to Rural Private Practice: How Two ODs are Using Handheld ERG to Embrace New Guidance from the Diabetic Retinopathy Taskforce

In September 2023, an important news release announced a consensus document, developed by a special task force made up of optometrists who have a...

The Five Pillars of Diabetic Retinopathy Management in Optometry

DETECT: Approach diabetic retinopathy as a chronic progressive disease. Being a chronic progressive disease implies that you can detect it before it becomes...

Women in the News – September 2023

Women In Optometry regularly recognizes the awards and accomplishments of women ODs in the profession and in their communities in the “Women in the News”...

CooperVision Opens Applications for 2024 Best Practices Honorees and Student Scholarship Recipients  

CooperVision today announced its ninth annual search for the nation’s Best Practices and student honorees. The initiative brings together eye care practices from all corners of the...